Golec, Joseph; Vernon, John - In: Applied Health Economics and Health Policy 7 (2009) 3, pp. 155-165
The biotech industry now accounts for a substantial and growing proportion of total R&D spending on new medicines. However, compared with the pharmaceutical industry, the biotech industry is financially fragile. This article illustrates the financial fragility of the biotech and pharmaceutical...
